Add like
Add dislike
Add to saved papers

Multifunctional UCNPs@MnSiO 3 @g-C 3 N 4 nanoplatform: improved ROS generation and reduced glutathione levels for highly efficient photodynamic therapy.

Biomaterials Science 2017 November 22
Photodynamic therapy (PDT) is a novel technique that has been extensively employed in cancer treatment; it utilizes reactive oxygen species to kill malignant cells. However, poor performance of the photosensitizer itself, limited penetration depth and the overexpression of glutathione (GSH) in cancer cells are the major obstacles facing the actual clinical application of PDT. Inspired by the challenges mentioned above, here we propose multifunctional nanoparticles utilizing mesoporous manganese silicate (MnSiO3 )-coated upconversion nanoparticles (UCNPs) as nanocarriers for loading highly fluorescent graphitic-phase carbon nitride quantum dots (g-C3 N4 QDs) to simultaneously act as a photosensitive drug and imaging agent. Surface modification of the nanoparticles with polyethylene glycol (PEG) endows the samples (denoted as UMCNs-PEG) with excellent biocompatibility and long-term in vivo circulation. Taking advantage of the inherent performance of the as-synthesized nanoparticles, multimodality imaging, including upconversion luminescence (UCL), computed tomography (CT) and magnetic resonance imaging (MRI), has been achieved; this is conducive to providing effective treatment information by real-time monitoring. In vivo photodynamic therapy to achieve effective tumor inhibition was then realized without inducing significant toxicity to treated mice. As a result, this work provides a novel paradigm with highly integrated functionalities which not only exhibits excellent prospects for imaging-guided photodynamic anticancer therapy but also encourages further exploration of new types of multifunctional nanoparticles for biomedical applications.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app